Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Akanda Corp. Common Shares
AKAN | US
3.54
USD0.25
7.60%
AKAN | US
About Akanda Corp. Common Shares
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
17/04/2026
Close
3.54
Open
3.27
High
3.57
Low
3.14
Akanda Corp. through its subsidiaries engages in the cultivation manufacture and distribution of cannabis products to patients worldwide. The company operates through Cultivation and Distribution segments. It intends to supply medicinal-grade cannabis and cannabis based medical and wellness products. The company was founded in 2018 and is headquartered in New Romney the United Kingdom.
View LessAKAN | US
Risk
111.6
Sharpe
-0.80
Luna's Score
43/100
Recommendation
Sell
Luna says (AKAN | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
90.5%1 month
111.6%3 months
149.5%6 months
138.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.10
Debt to equity
-1.04
Debt to assets
0.45
Ent. to EBITDA
-0.80
Ent. to rev.
3.09
PEG
-
Other Fundamentals
EBITDA
-5.73M
MarketCap
10.10M
MarketCap(USD)
10.10M
Div. yield
-
Op. margin
-521.92
Erngs. growth
-
Rev. growth
-70.10
Ret. on equity
-279.79
Short ratio
1.19
Short perc.
2.82
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.88
Range1M
3.00
Range3M
3.00
Volumes: Market Activity
Rel. volume
1.69
Price X volume
576.16K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.80 | - | Cheaper |
| Ent. to Revenue | 3.09 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.10 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 149.54 | - | Riskier |
| Debt to Equity | -1.04 | -1.88 | Expensive |
| Debt to Assets | 0.45 | 0.48 | Par |
| Market Cap | 10.10M | - | Emerging |
